Borrowing against future R&D grants through Rockinghorse and similar financiers is expensive.
https://rockinghorsegroup.com.au/
They also want security over the assets of the company. You know like that library of compounds and the IP we've paid for.
If it was high risk before, its even higher risk now.
- Forums
- ASX - By Stock
- BIT
- Ann: BIOTRON CLINICAL TRIAL RESULTS WEBINAR
Ann: BIOTRON CLINICAL TRIAL RESULTS WEBINAR, page-72
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
3.2¢ |
Change
0.002(6.67%) |
Mkt cap ! $28.87M |
Open | High | Low | Value | Volume |
3.1¢ | 3.3¢ | 3.1¢ | $13.79K | 424.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 329429 | 3.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.4¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 329429 | 0.032 |
3 | 81516 | 0.031 |
8 | 342305 | 0.030 |
3 | 1008888 | 0.029 |
4 | 468000 | 0.028 |
Price($) | Vol. | No. |
---|---|---|
0.034 | 100000 | 1 |
0.035 | 347547 | 4 |
0.037 | 537816 | 2 |
0.038 | 162500 | 1 |
0.039 | 317353 | 2 |
Last trade - 15.51pm 26/07/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |